Clinical Trial

A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Healthy Male Chinese Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is a phase I clinical study to evaluate the pharmacokinetics (PK) similarity of single dose subcutaneous injection of Ebronucimab with different production processes in Chinese healthy male subjects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-20.
Status change: Not Yet Recruiting → Completed 2026-06-24
Trial Details
NCT Number NCT07043283
Lead Sponsor Akeso
Conditions Healthy Subjects
Enrollment 230 participants
Start Date 2025-10-20
Primary Completion 2026-02-07 (estimated)
Study Completion 2026-02-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-26